Literature DB >> 12450605

Neuroprotective effects of statins may not be related to total and low-density lipoprotein cholesterol lowering.

Sabu J George1, Abhay J Dhond, Skip M Alderson, Michael D Ezekowitz.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12450605     DOI： 10.1016/s0002-9149(02)02841-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  3 in total

1.  Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease.

Authors:  Xuemei Huang; Honglei Chen; William C Miller; Richard B Mailman; Jennifer L Woodard; Peter C Chen; Dong Xiang; Richard W Murrow; Yi-Zhe Wang; Charles Poole
Journal:  Mov Disord       Date:  2007-02-15       Impact factor: 10.338

2.  Lovastatin modulates glycogen synthase kinase-3β pathway and inhibits mossy fiber sprouting after pilocarpine-induced status epilepticus.

Authors:  Chun-Yao Lee; Thomas Jaw; Huan-Chin Tseng; I-Chun Chen; Horng-Huei Liou
Journal:  PLoS One       Date:  2012-06-26       Impact factor: 3.240

3.  Enhanced oxidative stress response and neuroprotection of combined limb remote ischemic conditioning and atorvastatin after transient ischemic stroke in rats.

Authors:  Changhong Ren; Sijie Li; Kaiyin Liu; Gary B Rajah; Anbo Zhang; Rongrong Han; Yuanyuan Liu; Qingjian Huang; Haiyan Li; Yuchuan Ding; Xunming Ji
Journal:  Brain Circ       Date:  2017-12-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.